These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 27235920)

  • 1. Screening for Open Neural Tube Defects.
    Krantz DA; Hallahan TW; Carmichael JB
    Clin Lab Med; 2016 Jun; 36(2):401-6. PubMed ID: 27235920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects. South Australia 1986-1991.
    Chan A; Robertson EF; Haan EA; Ranieri E; Keane RJ
    Br J Obstet Gynaecol; 1995 May; 102(5):370-6. PubMed ID: 7542023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects.
    Wald NJ; Cuckle H; Brock JH; Peto R; Polani PE; Woodford FP
    Lancet; 1977 Jun; 1(8026):1323-32. PubMed ID: 69055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anomalies fœtales affectant le tube neural : Dépistage / diagnostic prénatal et prise en charge de la grossesse.
    Wilson RD
    J Obstet Gynaecol Can; 2016 Dec; 38(12S):S496-S511. PubMed ID: 28063560
    [No Abstract]   [Full Text] [Related]  

  • 5. Prenatal screening and diagnosis of neural tube defects.
    Cameron M; Moran P
    Prenat Diagn; 2009 Apr; 29(4):402-11. PubMed ID: 19301349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-trimester screening for neural tube defects using alpha-fetoprotein.
    Bredaki FE; Poon LC; Birdir C; Escalante D; Nicolaides KH
    Fetal Diagn Ther; 2012; 31(2):109-14. PubMed ID: 22377693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of maternal serum alpha fetoprotein with a Polish AFP radioimmunoassay--a suitable screening method for neural tube defects?].
    Schlosser H; Greiff R
    Zentralbl Gynakol; 1986; 108(15):914-8. PubMed ID: 2429479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal serum screening for neural tube defects and fetal chromosome abnormalities.
    Rose NC; Mennuti MT
    West J Med; 1993 Sep; 159(3):312-7. PubMed ID: 7694429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of neural tube defects in South Australia, 1966-91: effectiveness and impact of prenatal diagnosis.
    Chan A; Robertson EF; Haan EA; Keane RJ; Ranieri E; Carney A
    BMJ; 1993 Sep; 307(6906):703-6. PubMed ID: 8401091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal serum alpha-fetoprotein in fetal neural tube and abdominal wall defects at 10 to 14 weeks of gestation.
    Sebire NJ; Spencer K; Noble PL; Hughes K; Nicolaides KH
    Br J Obstet Gynaecol; 1997 Jul; 104(7):849-51. PubMed ID: 9236655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal serum alpha-fetoprotein screening for open neural tube defects in twin pregnancies.
    Cuckle H; Wald N; Stevenson JD; May HM; Ferguson-Smith MA; Ward AM; Barbour HM; Laurence KM; Norgaard-Pedersen B
    Prenat Diagn; 1990 Feb; 10(2):71-7. PubMed ID: 1692997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antecedent circumstances surrounding neural tube defect births in 1990-1991. The Steering Committee of the National Confidential Enquiry into Counselling for Genetic Disorders.
    Williamson P; Alberman E; Rodeck C; Fiddler M; Church S; Harris R
    Br J Obstet Gynaecol; 1997 Jan; 104(1):51-6. PubMed ID: 8988697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prenatal alpha fetoprotein screening for defects in the neural tube].
    Grob PJ
    Schweiz Med Wochenschr; 1978 Aug; 108(34):1302-7. PubMed ID: 80821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal diagnosis and elective termination of neural tube defects in Hawaii, 1986-1997.
    Forrester MB; Merz RD
    Fetal Diagn Ther; 2000; 15(3):146-51. PubMed ID: 10781998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for fetal malformations using ultrasound and measurements of alpha-fetoprotein in maternal serum.
    Persson PH; Kullander S; Gennser G; Grennert L; Laurell CB
    Br Med J (Clin Res Ed); 1983 Mar; 286(6367):747-9. PubMed ID: 6186332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural tube defects/alpha-fetoprotein/Down's syndrome screening.
    Aitken DA; Crossley JA
    Curr Opin Obstet Gynecol; 1997 Apr; 9(2):113-20. PubMed ID: 9204233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raised levels of maternal serum secretory acetylcholinesterase may be indicative of fetal neural tube defects in early pregnancy.
    Brennand DM; Jehanli AM; Wood PJ; Smith JL
    Acta Obstet Gynecol Scand; 1998 Jan; 77(1):8-13. PubMed ID: 9492710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for open neural tube defects.
    Krantz DA; Hallahan TW; Sherwin JE
    Clin Lab Med; 2010 Sep; 30(3):721-5. PubMed ID: 20638584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal serum screening in Ontario using the triple marker test.
    Summers AM; Farrell SA; Huang T; Meier C; Wyatt PR
    J Med Screen; 2003; 10(3):107-11. PubMed ID: 14561260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is maternal alpha-fetoprotein screening still of value in a low-risk area for neural tube defects?
    Hooker JG; Lucas M; Richards BA; Shirley IM; Thompson BD; Ward RH
    Prenat Diagn; 1984; 4(1):29-33. PubMed ID: 6203108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.